MR编号 | IS/H/0609/001 |
---|
药品名称 | Nintedanib Teva |
---|
活性成分 | - nintedanib esilate 100.0 mg
|
---|
剂型 | Capsule, soft |
---|
上市许可持有人 | Teva GmbH,
Graf-Arco-Str.3,
89079 Ulm,
Germany |
---|
参考成员国 - 产品名称 | Iceland (IS) Nintedanib Teva |
---|
互认成员国 - 产品名称 | - Slovenia (SI)
- Sweden (SE)
- Germany (DE)
Nintedanib Adalvo 100 mg Weichkapseln - Norway (NO)
- Denmark (DK)
- Finland (FI)
- Belgium (BE)
Nintedanib Teva 100 mg zachte capsules - Poland (PL)
Nintedanib Adalvo - Netherlands (NL)
- Latvia (LV)
- Luxembourg (LU)
- Lithuania (LT)
Nintedanib Adalvo 100 mg minkštosios kapsulės - Austria (AT)
- Estonia (EE)
- France (FR)
- Czechia (CZ)
Nintedanib Adalvo - Spain (ES)
- Romania (RO)
Nintedanib Adalvo 100 mg capsule moi - Ireland (IE)
- Portugal (PT)
- Slovakia (SK)
- Hungary (HU)
Nintedanob Teva 100mg lágy kapszula - Italy (IT)
- Croatia (HR)
- Cyprus (CY)
Nintedanib/Teva 100mg soft capsules - Greece (GR)
|
---|
许可日期 | 2023/12/21 |
---|
最近更新日期 | 2025/01/13 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|